287 related articles for article (PubMed ID: 30550614)
1. Inhibition of Diabetes-Induced Lysyl Oxidase Overexpression Prevents Retinal Vascular Lesions Associated With Diabetic Retinopathy.
Song B; Kim D; Nguyen NH; Roy S
Invest Ophthalmol Vis Sci; 2018 Dec; 59(15):5965-5972. PubMed ID: 30550614
[TBL] [Abstract][Full Text] [Related]
2. Decreased lysyl oxidase level protects against development of retinal vascular lesions in diabetic retinopathy.
Kim D; Mecham RP; Nguyen NH; Roy S
Exp Eye Res; 2019 Jul; 184():221-226. PubMed ID: 31022398
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of Lysyl Oxidase Protects Retinal Endothelial Cells From High Glucose-Induced Apoptosis.
Kim D; Mecham RP; Trackman PC; Roy S
Invest Ophthalmol Vis Sci; 2017 May; 58(5):2725-2731. PubMed ID: 28538980
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of Connexin 43 promotes vascular cell loss and excess permeability associated with the development of vascular lesions in the diabetic retina.
Tien T; Muto T; Barrette K; Challyandra L; Roy S
Mol Vis; 2014; 20():732-41. PubMed ID: 24940027
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of D-amino acid oxidase prevents retinal neurovascular pathologies in diabetic rats.
Jiang H; Zhang H; Jiang X; Wu S
Diabetologia; 2021 Mar; 64(3):693-706. PubMed ID: 33319325
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes.
Zhang J; Wu Y; Jin Y; Ji F; Sinclair SH; Luo Y; Xu G; Lu L; Dai W; Yanoff M; Li W; Xu GT
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):732-42. PubMed ID: 18235022
[TBL] [Abstract][Full Text] [Related]
7. Effects of High Glucose-Induced Lysyl Oxidase Propeptide on Retinal Endothelial Cell Survival: Implications for Diabetic Retinopathy.
Kim D; Lee D; Trackman PC; Roy S
Am J Pathol; 2019 Oct; 189(10):1945-1952. PubMed ID: 31537300
[TBL] [Abstract][Full Text] [Related]
8. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
[TBL] [Abstract][Full Text] [Related]
9. Reduced connexin 43 expression and its effect on the development of vascular lesions in retinas of diabetic mice.
Bobbie MW; Roy S; Trudeau K; Munger SJ; Simon AM; Roy S
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3758-63. PubMed ID: 20130277
[TBL] [Abstract][Full Text] [Related]
10. Aging increases retinal vascular lesions characteristic of early diabetic retinopathy.
Roy S; Tonkiss J; Roy S
Biogerontology; 2010 Aug; 11(4):447-55. PubMed ID: 20119717
[TBL] [Abstract][Full Text] [Related]
11. Normalization of retinal vascular permeability in experimental diabetes with genistein.
Nakajima M; Cooney MJ; Tu AH; Chang KY; Cao J; Ando A; An GJ; Melia M; de Juan E
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2110-4. PubMed ID: 11481279
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol blocks diabetes-induced early vascular lesions and vascular endothelial growth factor induction in mouse retinas.
Kim YH; Kim YS; Roh GS; Choi WS; Cho GJ
Acta Ophthalmol; 2012 Feb; 90(1):e31-7. PubMed ID: 21914146
[TBL] [Abstract][Full Text] [Related]
13. Methylglyoxal induces hyperpermeability of the blood-retinal barrier via the loss of tight junction proteins and the activation of matrix metalloproteinases.
Kim J; Kim CS; Lee YM; Jo K; Shin SD; Kim JS
Graefes Arch Clin Exp Ophthalmol; 2012 May; 250(5):691-7. PubMed ID: 22249316
[TBL] [Abstract][Full Text] [Related]
14. High glucose increases lysyl oxidase expression and activity in retinal endothelial cells: mechanism for compromised extracellular matrix barrier function.
Chronopoulos A; Tang A; Beglova E; Trackman PC; Roy S
Diabetes; 2010 Dec; 59(12):3159-66. PubMed ID: 20823103
[TBL] [Abstract][Full Text] [Related]
15. A long-term siRNA strategy regulates fibronectin overexpression and improves vascular lesions in retinas of diabetic rats.
Roy S; Nasser S; Yee M; Graves DT; Roy S
Mol Vis; 2011; 17():3166-74. PubMed ID: 22171163
[TBL] [Abstract][Full Text] [Related]
16. Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown.
Skondra D; Noda K; Almulki L; Tayyari F; Frimmel S; Nakazawa T; Kim IK; Zandi S; Thomas KL; Miller JW; Gragoudas ES; Hafezi-Moghadam A
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):726-31. PubMed ID: 18235021
[TBL] [Abstract][Full Text] [Related]
17. VEGF164 is proinflammatory in the diabetic retina.
Ishida S; Usui T; Yamashiro K; Kaji Y; Ahmed E; Carrasquillo KG; Amano S; Hida T; Oguchi Y; Adamis AP
Invest Ophthalmol Vis Sci; 2003 May; 44(5):2155-62. PubMed ID: 12714656
[TBL] [Abstract][Full Text] [Related]
18. Association of reduced Connexin 43 expression with retinal vascular lesions in human diabetic retinopathy.
Tien T; Muto T; Zhang J; Sohn EH; Mullins RF; Roy S
Exp Eye Res; 2016 May; 146():103-106. PubMed ID: 26738943
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal injection of erythropoietin protects against retinal vascular regression at the early stage of diabetic retinopathy in streptozotocin-induced diabetic rats.
Mitsuhashi J; Morikawa S; Shimizu K; Ezaki T; Yasuda Y; Hori S
Exp Eye Res; 2013 Jan; 106():64-73. PubMed ID: 23178551
[TBL] [Abstract][Full Text] [Related]
20. The cKit Inhibitor, Masitinib, Prevents Diabetes-Induced Retinal Vascular Leakage.
Kim SR; Im JE; Jeong JH; Kim JY; Kim JT; Woo SJ; Sung JH; Park SG; Suh W
Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1201-6. PubMed ID: 26978025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
